# A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

> **NCT01173536** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 61 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GDC-0449
- **DRUG:** moxifloxacin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01173536
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-25
- **Primary completion:** 2011-03-18
- **Final completion:** 2011-03-18
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2017-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173536, "A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01173536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*